As a molecular geneticist, affiliated with the Department of Pharmacology in Oxford (UK) and later with the pharmaceutical biotechnology industry in San Francisco (CA, USA), I have been involved in research projects investigating how the human body responds to pharmaceuticals and other exogenous chemicals of everyday life (called “xenobiotics”). This knowledge is particularly relevant when […]
Fulbright Schuman